Uncertainty in Accounting Estimates and Impairment Losses Due to COVID-19
First written in FY2020-Q2. 9 of 12 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
- FY2026-H1RestatedAnnual report
「There were no material changes in the significant accounting estimates and the assumptions used in those estimates described in the “Analysis of Financial Position, Operating Results and Cash Flows by Management” section of the previous fiscal year’s securities report.」
The company explained that there had been no material changes from the previous consolidated fiscal year in the significant accounting estimates and the assumptions used in those estimates. - FY2024MaterialisedAnnual report
「Property, plant and equipment decreased 1.9% from the end of the previous consolidated fiscal year to ¥2,004 million, mainly because of a decrease resulting from the reversal of deferred tax assets.」
Deferred tax assets decreased from ¥42.406 million to ¥5.042 million, and a reversal actually occurred during the fiscal year. - FY2023-Q3RestatedAnnual report
「There were no material changes in the significant accounting estimates and the assumptions used in those estimates described in the “Analysis of Financial Position, Operating Results and Cash Flows by Management” section of the previous fiscal year’s securities report.」
The company explained that there had been no material changes from the previous consolidated fiscal year in the significant accounting estimates and the assumptions used in those estimates. - FY2023-Q2RestatedAnnual report
「There were no material changes in the significant accounting estimates and the assumptions used in those estimates described in the “Analysis of Financial Position, Operating Results and Cash Flows by Management” section of the previous fiscal year’s securities report.」
The company explained that there had been no material changes from the previous consolidated fiscal year in the significant accounting estimates and the assumptions used in those estimates. - FY2023-Q1RestatedAnnual report
「The company stated that there had been no material changes from the previous consolidated fiscal year in the assumptions concerning the impact of the spread of COVID-19 described in the “Additional Information” section of the previous fiscal year’s securities report, under “Accounting Estimates Related to the Spread of COVID-19.”」
The company continued to state that there had been no material changes in the assumptions used for accounting estimates concerning the impact of COVID-19. - FY2022-Q2RestatedAnnual report
「The company stated that there had been no material changes from the previous consolidated fiscal year in the assumptions concerning the impact of the spread of COVID-19 described in the “Additional Information” section of the previous fiscal year’s securities report, under “Accounting Estimates Related to the Spread of COVID-19.”」
The company explained that there had been no material changes from the previous consolidated fiscal year in the assumptions used for accounting estimates concerning the impact of COVID-19. - FY2022-Q1RestatedAnnual report
「The company stated that there had been no material changes from the previous consolidated fiscal year in the assumptions concerning the impact of the spread of COVID-19 described in the “Additional Information” section of the previous fiscal year’s securities report, under “Accounting Estimates Related to the Spread of COVID-19.”」
The company explained that there had been no material changes from the previous consolidated fiscal year in the assumptions used for accounting estimates concerning the impact of COVID-19. - FY2021-Q2RestatedAnnual report
「The company stated that there had been no material changes from the previous consolidated fiscal year in the assumptions concerning the impact of the spread of COVID-19 described in the “Additional Information” section of the previous fiscal year’s securities report, under “Accounting Estimates Related to the Spread of COVID-19.”」
The company explained that there had been no material changes from the previous consolidated fiscal year in the assumptions used for accounting estimates concerning the impact of the disease. - FY2021-Q1RestatedAnnual report
「The company stated that there had been no material changes from the previous consolidated fiscal year in the assumptions concerning the impact of the spread of COVID-19 described in the “Additional Information” section of the previous fiscal year’s securities report, under “Accounting Estimates Related to the Spread of COVID-19.”」
The company explained that there had been no material changes from the previous consolidated fiscal year in the assumptions used for accounting estimates concerning the impact of the disease. - FY2020SoftenedAnnual report
「The company assumed that these conditions would continue for a certain period during the following consolidated fiscal year and made accounting estimates including impairment testing of fixed assets and assessing the recoverability of deferred tax assets.」
The assumption regarding the impact of the disease was changed from the previous assumption that conditions would generally return to pre-pandemic levels during the following consolidated fiscal year to an assumption that they would continue for a certain period during that fiscal year. - FY2020-Q3RestatedAnnual report
「The company assumed that these conditions would gradually recover by the end of the consolidated fiscal year and generally return to pre-pandemic levels during the following consolidated fiscal year, and made accounting estimates including impairment testing of fixed assets and assessing the recoverability of deferred tax assets. As a result, it recognized an impairment loss of ¥278.405 million and reversed ¥35.945 million of deferred tax assets during the nine-month period ended the third quarter.」
The company continued to assume that the impact of the disease would recover by the end of the consolidated fiscal year and return to pre-pandemic levels during the following consolidated fiscal year. It also continued to disclose an impairment loss of ¥278.405 million and the reversal of ¥35.945 million of deferred tax assets. - FY2020-Q2First statedAnnual report
「As the spread of COVID-19 led to production cuts by business partners and other factors, the Group’s revenue declined. The company made accounting estimates, including impairment testing of fixed assets and assessing the recoverability of deferred tax assets, based on the assumption that these conditions would gradually recover by the end of the consolidated fiscal year and would generally return to pre-pandemic levels during the following consolidated fiscal year. As a result, the company recognized an impairment loss of ¥278.405 million and reversed ¥35.945 million of deferred tax assets during the second-quarter consolidated accounting period. Because the impact of the disease on economic activity is highly uncertain, changes in the above assumptions may affect the Group’s future financial position and operating results.」
For the impact of the disease, the company made accounting estimates based on the assumption that conditions would gradually recover by the end of the consolidated fiscal year and return to pre-pandemic levels during the following consolidated fiscal year. As a result, it recorded an impairment loss of ¥278.405 million and reversed ¥35.945 million of deferred tax assets, and newly stated that changes in the assumptions could affect its future financial position and operating results.